Company
UroGen
Innovation that champions patients
Also known as UroGen Pharma, Inc.
- Status
- Operatingas of 2026-09-17
- Headquarters
- Princeton, NJ, United States
- Legal name
- UroGen Pharma, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
UroGen has a steadfast commitment to elevating options for people living with urological cancers. Through breakthrough technology, we are removing barriers to treatment and shaping a future filled with new possibilities in transformative therapies.
Funding snapshot
- Total raised
- $120MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $120M2023-07-26
Funding rounds
- Round, 2023
- $120M2023-07-26, SEC form D sold, 8 investors
Products
- Other
- Jelmyto
- Other
- Zusduri
Loading relationship preview